Please login to the form below

Not currently logged in

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

Envigo Patricia HenahanResearch company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer.

Henahan brings 15 years of financial experience in the life science sector, including senior leadership roles at AstraZeneca, Eli Lilly and MedImmune.

Most recently, she served as vice president of finance for Hospira's US commercial operations.

Brian Cass, chief executive officer at Envigo, said: “I am delighted that Pat has decided to join the team at Envigo.

“Her background in pharmaceuticals and experience across the research and development process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”

21st June 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge